|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
General
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving
Docetaxel
Chemotherapy
Young-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, Dong-Hoe Koo, Jung Hun Kang, Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Dae-Won Lee, Joohyuk Sohn, So Yeon Oh, Kyung Hee Lee, Su-Jin Koh, Keun Seok Lee, Chan-Kyu Kim, Ji-Yeon Kim, Jun Ho Ji, Sung-Bae Kim, Joo Young Ha, Ho Young Kim
Cancer Res Treat.
2023;55(4):1096-1103. Published online April 7, 2023 DOI:
https://doi.org/10.4143/crt.2022.1565
Breast cancer
Real-World Evidence of Trastuzumab, Pertuzumab, and
Docetaxel
Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer
Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Cancer Res Treat.
2022;54(4):1130-1137. Published online January 17, 2022 DOI:
https://doi.org/10.4143/crt.2021.1103
Web of Science 2
Crossref 3
Head and Neck cancer
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly
Docetaxel
as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer
Hye Ryeon Kim, Su Jin Lee, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Han-Sin Jeong, Man Ki Chung, Myung-Ju Ahn
Cancer Res Treat.
2022;54(3):719-727. Published online November 1, 2021 DOI:
https://doi.org/10.4143/crt.2021.1019
Web of Science 6
Crossref 4
Breast cancer
Potentiation of the Anticancer Effects by Combining
Docetaxel
with Ku-0063794 against Triple-Negative Breast Cancer Cells
Ye-Won Jeon, Ok-Hee Kim, Jin Sun Shin, Ha Eun Hong, Cho Hee Kim, Say-June Kim
Cancer Res Treat.
2022;54(1):157-173. Published online April 5, 2021 DOI:
https://doi.org/10.4143/crt.2020.1063
Web of Science 2
Crossref 4
Prediction of Acquired Taxane Resistance Using a Personalized Pathway-Based Machine Learning Method
Young Rae Kim, Dongha Kim, Sung Young Kim
Cancer Res Treat.
2019;51(2):672-684. Published online August 10, 2018 DOI:
https://doi.org/10.4143/crt.2018.137
Web of Science 6
Crossref 6
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
Choong-kun Lee, Minkyu Jung, Hyo Song Kim, Inkyung Jung, Dong Bok Shin, Seok Yun Kang, Dae Young Zang, Ki Hyang Kim, Moon Hee Lee, Bong-Seog Kim, Kyung Hee Lee, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Hyun Cheol Chung, Sun Young Rha
Cancer Res Treat.
2019;51(1):1-11. Published online February 5, 2018 DOI:
https://doi.org/10.4143/crt.2018.028
Web of Science 21
Crossref 11
Gemcitabine and
Docetaxel
Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study
Yunjung Choi, Mi Sun Yun, Sang Hee Lim, Jeeyun Lee, Jin-Hee Ahn, Yu Jung Kim, Kyong Hwa Park, Young Suk Park, Ho Yeong Lim, Hyonggin An, Dong-Churl Suh, Yeul Hong Kim
Cancer Res Treat.
2018;50(1):175-182. Published online March 30, 2017 DOI:
https://doi.org/10.4143/crt.2016.535
Web of Science 15
Crossref 18
A Multicenter Randomized Phase II Study of
Docetaxel
vs.
Docetaxel
Plus Cisplatin vs.
Docetaxel
Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
Keun-Wook Lee, Bum Jun Kim, Mi-Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, Sook Ryun Park
Cancer Res Treat.
2017;49(3):706-716. Published online October 18, 2016 DOI:
https://doi.org/10.4143/crt.2016.216
Web of Science 12
Crossref 12
East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of
Docetaxel
and Ramucirumab Versus
Docetaxel
and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)
Keunchil Park, Joo-Hang Kim, Eun Kyung Cho, Jin-Hyoung Kang, Jin-Yuan Shih, Annamaria Hayden Zimmermann, Pablo Lee, Ekaterine Alexandris, Tarun Puri, Mauro Orlando
Cancer Res Treat.
2016;48(4):1177-1186. Published online February 22, 2016 DOI:
https://doi.org/10.4143/crt.2015.401
Web of Science 16
Crossref 14
Caveolin-1 Modulates
Docetaxel
-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms
Jinho Kang, Joo Hee Park, Hye Jin Lee, Ukhyun Jo, Jong Kuk Park, Jae Hong Seo, Yeul Hong Kim, Insun Kim, Kyong Hwa Park
Cancer Res Treat.
2016;48(2):715-726. Published online September 21, 2015 DOI:
https://doi.org/10.4143/crt.2015.227
Web of Science 21
Crossref 18
Results of a Phase II Study to Evaluate the Efficacy of
Docetaxel
and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
Choong-kun Lee, Minkyu Jung, Hye Jin Choi, Hye Ryun Kim, Hyo Song Kim, Mi Ryung Roh, Joong Bae Ahn, Hyun Cheol Chung, Su Jin Heo, Sun Young Rha, Sang Joon Shin
Cancer Res Treat.
2015;47(4):781-789. Published online February 16, 2015 DOI:
https://doi.org/10.4143/crt.2014.261
Web of Science 7
Crossref 8
Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with
Docetaxel
Chemotherapy
Jung Ran Choi, Jeong-Oh Kim, Dae Ryong Kang, Jung-Young Shin, Xiang Hua Zhang, Ji Eun Oh, Ji-Young Park, Kyoung-Ah Kim, Jin-Hyoung Kang
Cancer Res Treat.
2015;47(3):509-517. Published online December 16, 2014 DOI:
https://doi.org/10.4143/crt.2014.012
Web of Science 33
Crossref 28
Outcomes of Third-Line
Docetaxel
-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies
Min Jeong Lee, In Gyu Hwang, Joung-Soon Jang, Jin Hwa Choi, Byeong-Bae Park, Myung Hee Chang, Seung Tae Kim, Se Hoon Park, Myoung Hee Kang, Jung Hun Kang
Cancer Res Treat.
2012;44(4):235-241. Published online December 31, 2012 DOI:
https://doi.org/10.4143/crt.2012.44.4.235
Crossref 22
Weekly Gemcitabine and
Docetaxel
in Refractory Soft Tissue Sarcoma: A Retrospective Analysis
Ha-young Lee, Sang Joon Shin, Hyo Song Kim, Soo Jung Hong, Jung Woo Han, Seung Taek Lim, Jae Kyung Roh, Sun Young Rha
Cancer Res Treat.
2012;44(1):43-49. Published online March 31, 2012 DOI:
https://doi.org/10.4143/crt.2012.44.1.43
Crossref 13
Phase II Study of S-1 Plus Either Irinotecan or
Docetaxel
for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment
Dal Yong Kim, Dae Ho Lee, Sun-Joo Jang, Sang-We Kim, Cheolwon Suh, Jung Shin Lee
Cancer Res Treat.
2011;43(4):212-216. Published online December 27, 2011 DOI:
https://doi.org/10.4143/crt.2011.43.4.212
Crossref 1
Efficacy and Safety of
Docetaxel
Plus Prednisolone Chemotherapy for Metastatic Hormone-Refractory Prostate Adenocarcinoma: Single Institutional Study in Korea
Jae-Lyun Lee, Jeong Eun Kim, Jin-Hee Ahn, Dae-Ho Lee, Jungshin Lee, Choung-Soo Kim, Jun Hyuk Hong, Bumsik Hong, Cheryn Song, Hanjong Ahn
Cancer Res Treat.
2010;42(1):12-17. Published online March 31, 2010 DOI:
https://doi.org/10.4143/crt.2010.42.1.12
Crossref 18
Docetaxel
versus Paclitaxel Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials
Hong Jae Chon, Sun Young Rha, Chong Kun Im, Chan Kim, Min Hee Hong, Hye Ryun Kim, Jung Ryun An, Sung Hoon Noh, Hyun Cheol Chung, Hei-Cheul Jeung
Cancer Res Treat.
2009;41(4):196-204. Published online December 31, 2009 DOI:
https://doi.org/10.4143/crt.2009.41.4.196
Crossref 22
A Phase II Study of Leucovorin, 5-FU and
Docetaxel
Combination Chemotherapy in Patients with Inoperable or Postoperative Relapsed Gastric Cancer
Kwang-Sun Lee, Ha-Yeon Lee, Eun-Kyung Park, Joung-Soon Jang, Sang-Jae Lee
Cancer Res Treat.
2008;40(1):11-15. Published online March 31, 2008 DOI:
https://doi.org/10.4143/crt.2008.40.1.11
Crossref 2
The Efficacy of an Induction Chemotherapy Combination with
Docetaxel
, Cisplatin, and 5-FU Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Cancer
Jae-Sook Ahn, Sang-Hee Cho, Ok-Ki Kim, Joon-Kyoo Lee, Deok-Hwan Yang, Yeo-Kyeoung Kim, Je-Jung Lee, Sang-Chul Lim, Hyeoung-Joon Kim, Woong-Ki Chung, Ik-Joo Chung
Cancer Res Treat.
2007;39(3):93-98. Published online September 30, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.3.93
Crossref 17
Phase II Study of
Docetaxel
and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric Cance
Kyung-Ha Kim, Ki-Ju Jeung, Hyun-Jung Kim, Sang-Byung Bae, Chan-Kyu Kim, Nam-Su Lee, Kyu-Taek Lee, Sung-Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park
Cancer Res Treat.
2007;39(2):49-53. Published online June 30, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.2.49
Crossref 4
Induction Chemotherapy of
Docetaxel
and Cisplatin for the Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
Young-Jin Choi, Jooseop Chung, Ho-Jin Shin, Goon-Jae Cho, Soo-Geun Wang, Byung-Joo Lee, Byung-Mann Cho, Dong-Won Kim, Hak-Jin Kim, Won Sik Lee, Young-Don Joo, Chang-Hak Sohn
Cancer Res Treat.
2007;39(1):1-5. Published online March 31, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.1.1
Crossref 8
The Safety and Efficacy of Second-line Single
Docetaxel
(75 mg/m
2
) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy
Byoung Yong Shim, Chi Hong Kim, So Hyang Song, Meyung Im Ahn, Eun Jung Hong, Sung Whan Kim, Suzy Kim, Min Seop Jo, Deog Gon Cho, Kyu Do Cho, Jinyoung Yoo, Hoon-Kyo Kim
Cancer Res Treat.
2005;37(6):339-343. Published online December 31, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.6.339
Crossref 5
Randomized, Multi-center Phase II Trial of
Docetaxel
Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer
Nam-Su Lee, Hee-Sook Park, Jong-Ho Won, Dae-Sik Hong, Su-Taek Uh, Sang-Jae Lee, Joo-Hang Kim, Se-Kyu Kim, Myung-Ju Ahn, Jung-Hye Choi, Suk-Chul Yang, Jung-Ae Lee, Keun-Seok Lee, Chang-Yeol Yim, Yong-Chul Lee, Chul-Soo Kim, Moon-Hee Lee, Kab-Do Jung, Hanlim Moon, Yl-Sub Lee
Cancer Res Treat.
2005;37(6):332-338. Published online December 31, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.6.332
Crossref 1
Efficacy and Safety Study of
Docetaxel
as Salvage Chemotherapy in Metastatic Gastric Cancer Failing Fluoropyrimidine and Platinum Combination Chemotherapy
Jae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, Tae-Won Kim, Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim, Jung Shin Lee, Yoon-Koo Kang
Cancer Res Treat.
2005;37(4):201-207. Published online August 31, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.4.201
Crossref 4
The Efficacy of
Docetaxel
and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer after Failing to 5-Fluorouracil Based Chemotherapy
Sang-Joon Shin, Min-Kyoung Kim, Kyung-Hee Lee, Myung-Soo Hyun, Sang Woon Kim, Sun Kyo Song, Sung-Hwa Bae, Hun-Mo Ryoo
Cancer Res Treat.
2004;36(6):367-371. Published online December 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.6.367
Crossref 5
A Phase II Trial of
Docetaxel
and Ifosfamide for Patients with Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting
Gyeong-Won Lee, Jung-Hun Kang, Seok-Hyun Kim, Hea Yong Lee, Ho-Cheol Kim, Won-Sup Lee, Jong-Duk Lee, Young-Sil Hwang, Joung-Soon Jang, Jong-Seok Lee
Cancer Res Treat.
2004;36(5):287-292. Published online October 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.5.287
Crossref 1
Effect of Combination Chemotherapy with
Docetaxel
Plus Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
Hee Jung Kang, Min Kyoung Kim, Young Gil Kim, Jae Lyun Lee, Kyung Hee Lee, Myung Soo Hyun, Sung Hwa Bae, Hun Mo Ryoo
Cancer Res Treat.
2003;35(4):299-303. Published online August 31, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.4.299
Docetaxel
and Cisplatin Combination Chemotherapy in Patients with Squamous Cell Carcinomas of the Head and Neck
Jung Hyun Lee, Kyung Woo Lee, Young Jin Choi, Jae Hoon Choi, Ho Jin Shin, Joo Seop Chung, Goon Jae Cho, Byung Ju Lee, Soo Geun Wang
Cancer Res Treat.
2003;35(3):261-266. Published online June 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.3.261
Crossref 2
Infusional 5-Fluorouracil, Leucovorin and
Docetaxel
in Advanced Gastric Cancer
Yong Tai Kim, Joo Hyuk Sohn, So Hun Kim, Sun Young Rha, Chul Kim, Jae Kyung Roh, Byung Soo Kim, Woo Ick Jang, Hyun Cheol Chung
Cancer Res Treat.
2003;35(2):123-129. Published online April 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.2.123
Crossref 1
The Efficacy and Safety of
Docetaxel
in Patients with Anthracychne pretreated Metastatic Breast Cancer: A Multicenter Phase II Study
Joong Bae Ahn, Kwang Yong Shim, Joon Oh Park, Hei Chul Jung, Nae Choon Yoo, Hyun Cheol Chung, Joo Hang Kim, Jin Hyuk Choi, Hyun Soo Kim, Hugh Chul Kim, Woo Kun Kim, Jae Kyung Roh
J Korean Cancer Assoc.
2000;32(2):235-243.
1
Journal Impact Factor 4.6